Results 131 to 140 of about 13,218 (206)

Impact of HAART therapy on cognitive function in patients with HIV: a systematic review of randomized control trial. [PDF]

Ann Med Surg (Lond)
Al Diab Al Azzawi M, Alhamed AM, Almajed H, Ahmed WA, Alshahrani NNA, Idris IS, Aldayhani OB, Fallatah F, Bedaiwi RH.   +8 more
europepmc   +1 more source

Longitudinal Clinical and Molecular Characterization of a Single Pediatric Case of Vertically Acquired HIV-1 Subtype C with Baseline Resistance to Protease Inhibitors. [PDF]

Microorganisms
Zaher KA, El-Daly MM, Zaki EA, Alhazmi MM, Abdulhaq A, El-Kafrawy SA, Azhar EI.   +6 more
europepmc   +1 more source

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1. [PDF]

Open Forum Infect Dis
Molina JM, Orkin C, Paredes R, Xu ZJ, Su FH, Asante-Appiah E, Plank RM, Lahoulou R.   +7 more
europepmc   +1 more source

Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens. [PDF]

AIDS
Marcelin AG, Soulie C, Wirden M, Gruber J, Prata Menezes N, Lim T, Barriere G, Descamps D, Charpentier C, Calvez V.   +9 more
europepmc   +1 more source

Early outcomes of South African children with persistent viral non-suppression following switch to dolutegravir-based antiretroviral therapy. [PDF]

South Afr J HIV Med
Guerrini M, Maré M, Hulsman C, Greybe L, Lishman J, Edson C, Hisham T, Frigati L, Rabie H.   +8 more
europepmc   +1 more source

Choosing between dual and three-drug antiretroviral therapy in aging and comorbid people with HIV: a narrative review. [PDF]

Front Reprod Health
Cossu MV, Matone M, Iannone V, Fusetti C, Colombo V, Gori A, Ridolfo AL, Gervasoni C.   +7 more
europepmc   +1 more source

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV. [PDF]

Antimicrob Agents Chemother
Tsirizani L, Waalewijn H, Szubert A, Mulenga V, Chabala C, Bwakura-Dangarembizi M, Chitsamatanga M, Rutebarika DA, Musiime V, Kasozi M, Lugemwa A, McIlleron HM, Burger DM, Gibb DM, Colbers A, Denti P, Wasmann RE, CHAPAS-4 trial team.   +17 more
europepmc   +1 more source

Laser Microinterferometry for API Solubility and Phase Equilibria: Darunavir as a Case Example. [PDF]

Pharmaceutics
Makarova V, Mandrik M, Antonov S.
europepmc   +1 more source

Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study. [PDF]

Virol J
Mayini J, Washaya T, Manasa J, Zumbika E, Munyati S, Shoko R, Dahlke C, Kouamou V.   +7 more
europepmc   +1 more source

Cutting-edge developments in computer-aided anti-HIV drug design. [PDF]

Front Immunol
Yang W, Wang Y, Feng C, Tang W, Sun L.
europepmc   +1 more source